1. Fair Play and Editorial Independence

Editors at the International Journal of Clinical Obstetrics and Gynaecology Nexovation evaluate manuscripts based solely on academic merit—importance, originality, clarity, scientific validity, and relevance to clinical obstetrics and gynecology—without regard to authors’ race, gender, sexual orientation, religious beliefs, ethnic origin, citizenship, or institutional affiliation. The Editor-in-Chief has full editorial independence and makes final publication decisions without external influence.

2. Confidentiality

All submitted manuscripts are confidential documents. Editors must not disclose information about a manuscript to anyone other than the corresponding author, reviewers, potential reviewers, and the publisher, as appropriate.

3. Disclosure and Conflicts of Interest

Editors must not use unpublished information from submitted manuscripts for their own research without written permission from the author. If an editor has a conflict of interest with any manuscript, they must recuse themselves from its review and delegate it to another qualified editor.

4. Publication Decisions

All manuscripts submitted to the journal undergo double-blind peer review by at least two experts in clinical obstetrics or gynecology. The Editor-in-Chief, considering reviewer recommendations, scholarly value, and ethical guidelines, is responsible for final publication decisions.

5. Ethical Investigations

Editors, together with the publisher, investigate all credible allegations of research misconduct or ethical violations. Following COPE guidelines, corrections, retractions, or expressions of concern will be issued as appropriate.

Duties of Reviewers

1. Contribution to Editorial Decisions

Reviewers provide critical assessments that assist editors in making informed publication decisions and support authors in improving the quality of their work. Peer review upholds the quality of scientific discourse in clinical obstetrics and gynecology.

2. Timeliness

Reviewers who cannot complete the review on time or feel unqualified to assess a manuscript should immediately inform the editors to ensure efficient review processes.

3. Confidentiality

Reviewers must treat manuscripts as confidential documents. Discussion with third parties is not permitted without editor approval.

4. Objectivity and Constructive Criticism

Reviews must be objective and provide clear, constructive feedback on scientific accuracy, study design, ethical compliance, clinical relevance, and clarity. Personal criticism of authors is inappropriate.

5. Acknowledgment of Sources

Reviewers should identify uncited work that is relevant, particularly foundational or recent advances in obstetrics and gynecology. Similarities to other known studies or suspected plagiarism should be reported to the editor.

6. Disclosure and Conflicts of Interest

Reviewers must disclose any conflicts of interest and refrain from using information from the manuscript for personal or competitive gain. Unpublished material must remain confidential.

Duties of Authors

1. Reporting Standards

Authors should present accurate, original research with sufficient detail and references for replication. Review articles and case reports must be balanced and clearly identified as such.

2. Data Access and Retention

Authors must be prepared to provide raw data upon request and retain it for at least 10 years following publication, ensuring compliance with patient privacy and ethical guidelines.

3. Originality and Plagiarism

Submitted work must be original and properly cited. Plagiarism or duplicate publication is unethical and strictly prohibited.

4. Multiple or Redundant Publication

Authors should not submit the same work to more than one journal simultaneously. Redundant publication without proper disclosure and permission is not acceptable.

5. Authorship Criteria

Authorship should reflect substantial contributions to the conception, design, execution, and interpretation of the research. All authors must approve the final manuscript and agree to submission. Others should be acknowledged with consent.

6. Disclosure and Conflicts of Interest

Authors must declare any financial or non-financial conflicts of interest and disclose all sources of funding.

7. Acknowledgment of Sources

Authors must cite all data, ideas, or previously published material used in the manuscript. Confidential communications should only be used with explicit permission.

8. Ethical Use of Human and Animal Subjects

Manuscripts involving human or animal subjects must include statements of ethical approval and informed consent. Patient anonymity must be preserved, and clinical trials must be registered.

9. Participation in Peer Review

Authors are expected to engage actively in the peer review process by revising manuscripts as per feedback and responding professionally.

10. Corrections and Retractions

Authors should inform the editors if they discover significant errors in their published work and cooperate in publishing corrections or retractions.

Duties of the Publisher

Handling Misconduct

The publisher, in collaboration with the editorial board, investigates cases of suspected research misconduct and unethical behavior. Appropriate action—including corrections, retractions, or bans—will be taken based on the findings.

Supporting Integrity

The publisher ensures the implementation of industry-standard ethical practices, supports editorial independence, and promotes transparency and accountability in scientific publishing.